Showing results (181-190 of 238) with videos related to

Sort By:
Pageof 24
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Dopamine receptor expression and function in human normal adrenal gland and adrenal tumorsRosario Pivonello, Diego Ferone, Wouter W de Herder, et al.
Metabolism: Clinical and Experimental|December 3, 2014
Glucose-dependent leukocyte activation in patients with type 2 diabetes mellitus, familial combined hyperlipidemia and healthy controlsMarijke A de Vries, Arash Alipour, Boudewijn Klop, et al.
Anticancer Research|February 7, 2016
A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine TumoursNicola Fazio, Roberto Buzzoni, Eric Baudin, et al.
The Lancet. Oncology|January 8, 2008
Gastroenteropancreatic neuroendocrine tumoursIrvin M Modlin, Kjell Oberg, Daniel C Chung, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2012
Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegalyFederico Gatto, Richard A Feelders, Rob van der Pas, et al.
Endocrine-Related Cancer|June 4, 2014
Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumorsMaria Cristina De Martino, Richard A Feelders, Wouter W de Herder, et al.
Seminars in Nuclear Medicine|April 20, 2002
Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experienceRoelf Valkema, Marion De Jong, Willem H Bakker, et al.
BMC Cancer|April 7, 2019
Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfallsCarolien M Beukhof, Tessa Brabander, Francien H van Nederveen, et al.
European Journal of Clinical Investigation|February 2, 2017
Erythrocyte-bound apolipoprotein B in atherosclerosis and mortalityMarijke A de Vries, Selvetta S van Santen, Boudewijn Klop, et al.
Pageof 24